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9 ABSTRACT: Polyproline sequences are highly abundant in prokaryotic
10 and eukaryotic proteins, where they serve as key components of
11 secondary structure. To date, construction of the proline−proline motif
12 has not been possible owing to steric congestion at the ligation junction,
13 together with an n → π* electronic interaction that reduces the
14 reactivity of acylated proline residues at the C-terminus of peptides.
15 Here, we harness the enhanced reactivity of prolyl selenoesters and a
16 trans-γ-selenoproline moiety to access the elusive proline−proline
17 junction for the ﬁrst time through a diselenide−selenoester ligation−
18 deselenization manifold. The eﬃcient nature of this chemistry is
19 highlighted in the high-yielding one-pot assembly of two proline-rich
20 polypeptide targets, submaxillary gland androgen regulated protein 3B
21 and lumbricin-1. This method provides access to the most challenging of ligation junctions, thus enabling the construction of
22 previously intractable peptide and protein targets of increasing structural complexity.
23 ■ INTRODUCTION
24 Peptide ligation chemistry has revolutionized protein science by
25 providing a means to access large polypeptide and protein
26 targets,1−3 including those that cannot be generated by
27 recombinant expression technologies. This includes the ability
28 to site-speciﬁcally incorporate nonproteinogenic amino acids,
29 post-translational modiﬁcations, and/or isotopic or ﬂuorescent
30 labels.2 The most widely adopted method for the convergent
31 assembly of peptide fragments to aﬀord large polypeptides and
32 proteins is undoubtedly native chemical ligation (NCL). This
33 technology, ﬁrst reported by Kent and co-workers,4 involves the
34 chemoselective reaction of a peptide possessing a C-terminal
35 thioester functionality with a second fragment bearing an N-
36 terminal cysteine (Cys) residue. While this technology has
37 enabled access to numerous protein targets to date,1−3 the
38 conventional reaction is limited by the requirement of a Cys
39 residue at the ligation junction. This restriction has, however,
40 been recently addressed through the development of NCL at
41 thiol-derived amino acids,5 selenocysteine,6−8 and a number of
42 synthetic selenol-derived amino acids9 that can serve as cysteine
43 surrogates in reactions with peptide thioesters. Importantly,
44 following the ligation reaction, these thiol and selenol auxiliaries
45 can be removed through desulfurization or deselenization
46 chemistry, respectively, to aﬀord native polypeptides and
47 proteins.10 One further limitation of the NCL manifold is that
48 reactions typically proceed slowly at sterically encumbered
49 thioesters, particularly those containing a C-terminal β-
50branched residue, e.g., valine (Val), threonine (Thr), or
51isoleucine (Ile).11 Furthermore, thioesters bearing a C-terminal
52proline (Pro) residue have proven to be unreactive acyl donors
53in traditional NCL reactions, including at Cys, selenocysteine
54(Sec), and thiol/selenol amino acids.12,13 This lack of reactivity
55has been attributed to a reduction in electrophilicity of the
56thioester due to a stabilizing n→ π* electron donation from the
57proximal amide carbonyl to the carbonyl of the thioester
58moiety.14,15 This stabilizing interaction is enabled by the rigid
59trans-conﬁgured peptide bond induced by the cyclic Pro
60residue.14,15 Attempts to overcome the challenge of performing
61ligation chemistry at Pro thioesters have focused on enhancing
62the reactivity of the acyl donor component. One approach has
63involved substituting the prolyl thioester with a more reactive
64 s1selenoester functionality (Scheme 1A).16 These selenoester acyl
65donors have been reported to react with N-terminal Cys-
66containing peptides, albeit in the presence of a selenol catalyst
67and a large molar excess of the acyl donor fragment. More
68recently, Dong et al. have designed a prolyl thioester whereby
69the γ-position of the Pro ring is functionalized with a thiol
70moiety (Scheme 1B).17 This modiﬁed Pro thioester reacts via a
71bicyclic thiolactone intermediate, which leads to activation of
72the carbonyl through the generation of a highly strained cyclic
73thioester. While this is a very elegant strategy, the γ-thiol
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74 auxiliary must be removed via a postligation desulfurization
75 protocol and therefore lacks chemoselectivity in the presence of
76 native Cys residues found elsewhere in the sequence.
77 Danishefsky and co-workers have reported the use of both
78 thioproline and selenoproline residues in NCL reactions with
79 peptide thioesters (Scheme 1C).13,18 These ligation reactions
80 worked well at unhindered sites, but were ineﬃcient at more
81 sterically encumbered C-terminal thioesters, e.g., Val, even with
82 the enhanced nucleophilicity of the selenoproline moiety.
83 Importantly, when peptides bearing N-terminal thioproline or
84 selenoproline residues were reacted with peptide thioesters
85 bearing a C-terminal Pro, no reaction was observed. This
86 inability to forge Pro−Pro was attributed to the deactivation of
87 the Pro thioester component through the n → π* interaction
88 from the adjacent carbonyl (vide supra).
89 We have recently reported the development of an additive-
90 free peptide ligation reaction between peptides bearing a C-
91 terminal selenoester and peptides containing an N-terminal
92 selenocystine residue (the oxidized form of Sec).12 Importantly,
93 these represent the fastest ligation reactions known, proceeding
94 eﬃciently in aqueous buﬀer without the addition of external
95 catalysts or reductants to aﬀord selenopeptide products in
96 minutes (including at selenoesters bearing C-terminal β-
97 branched amino acids). Upon reaction completion, and without
98 puriﬁcation, the selenocystine at the ligation junction can be
99 cleanly converted to alanine or serine through reductive19,20 or
100 oxidative deselenization,21,22 respectively. This diselenide−
101 selenoester ligation (DSL) manifold has been extended to
102 alternative selenol-derived amino acids including β-selenoas-
103 partate, β-selenoleucine, and γ-selenoglutamate and has been
104 successfully employed for the rapid and high-yielding synthesis
105 of a number of protein and selenoprotein targets.23,24 Following
106 the establishment of the DSL technology, we were interested in
107 probing whether the method could be used for the construction
108 of peptides at more challenging junctions. Herein, we describe
109 our eﬀorts to extend the application of DSL−deselenization to
110amino acid junctions containing Pro; we outline the ﬁrst
111example of the construction of challenging and hitherto
112inaccessible Pro−Pro junctions through ligation chemistry
113(Scheme 1D), as well as the application of this method in the
114synthesis of two large Pro-rich polypeptide targets.
115■ RESULTS AND DISCUSSION
116Design and Synthesis of a γ-Selenoproline Building
117Block. Before embarking on the development of the DSL
118methodology at Pro, we ﬁrst needed to prepare a suitably
119protected selenol-derived Pro residue that would be compatible
120with solid-phase synthesis protocols and the ensuing ligation
121chemistry. Danishefsky and co-workers have previously reported
122the preparation of a γ-selenoproline diselenide amino acid.13 We
123initially replicated this synthetic route (see Supporting
124Information), but as reported for other diselenide building
125blocks,12 we observed that only one-half of the diselenide amino
126acid was able to couple to a resin-bound peptide chain (i.e., the
127other selenoproline unit within the diselenide dimer was unable
128to couple to another peptide N-terminus). This is particularly
129problematic in larger immobilized targets or when peptides are
130more highly loaded on resin supports (>0.5 mmol/g). In order
131to mitigate these issues, we sought to synthesize a monomeric
132selenoproline building block 1, whereby the γ-selenol moiety
133was orthogonally protected with a p-methoxy benzyl group
134(PMB). The synthesis began with the C-terminal protection of
135commercially available trans-γ-hydroxyproline 2 as methyl ester
136 s23 (Scheme 2A). Conversion to cis-γ-iodoproline 4 was then
137performed under Mitsunobu conditions with inversion of
138stereochemistry at the γ-position. Direct treatment of iodide 4
139with 4-methoxybenzyldiselenide 5 in the presence of NaBH4
140then provided trans-γ-selenoproline methyl ester 6. Finally,
Scheme 1. Ligation Reactions between (A) a Prolyl
Selenoester and Cysteinyl Peptide; (B) a Thiolated Prolyl
Thioester and Cysteinyl Peptide That Proceeds via a
Thiolactone Intermediate; (C) Thioesters and Thio- or
Selenoproline Peptides; (D) a Prolyl Selenoester and
Selenoproline Peptides via Diselenide−Selenoester Ligation
(DSL)
Scheme 2. (A) Synthetic Route to trans-γ-Selenoproline 1;
(B) Incorporation of trans-γ-Selenoproline 1 Building Block
into Model Peptide 7 via Fmoc-SPPS
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141 saponiﬁcation of the methyl ester aﬀorded the target trans-γ-
142 selenoproline amino acid 1 in good yield over the four steps.
143 Synthesis of Peptides Bearing γ-Selenoproline. With
144 monomeric selenoproline building block 1 in hand, we next
145 investigated the eﬃciency of incorporation into the N-terminus
146 of Rink amide resin immobilized pentapeptide 7 loaded at 0.7
147 mmol/g (Scheme 2B). We were pleased to observe complete
148 coupling to 7 using only a slight excess of 1 (1.2 equiv) under
149 standard coupling conditions [hydroxyazabenzotriazole (1.2
150 equiv), (dimethylamino)isopropyl chloride hydrochloride (1.2
151 equiv), in dimethylformamide] to generate resin-bound
152 selenopeptide 8. Acidolytic side-chain deprotection with
153 concomitant cleavage from the resin followed by deprotection
154 of the PMB group (using 20% dimethylsulfoxide, 5% iPr3SiH in
155 triﬂuoroacetic acid) and puriﬁcation via reverse-phase HPLC
156 provided the model diselenide dimer peptide 9 in 50% yield
157 (based on the resin loading of the ﬁrst amino acid).
158 One-Pot DSL−Deselenization at γ-Selenoproline.With
159 model peptide 9 in hand, the ability of the diselenoproline motif
160 to participate in additive-free peptide ligation chemistry with a
161 range of model selenoesters (Ac-LYRANX-SePh) was inves-
t1 162 tigated (Table 1). We ﬁrst assessed the reaction of 9 with
163 peptide selenoesters 10−14 bearing C-terminal Ala (A), Met
164 (M), Tyr (Y), Leu (L), and Val (V) residues as a representative
165 selection of the proteinogenic amino acids (see Supporting
166 Information for details on peptide selenoester synthesis).
167 Speciﬁcally, diselenide dimer 9 and peptide selenoesters 10−
168 14 (1.3 equiv with respect to monomeric 9) were simply
169 dissolved in 6 M guanidinium chloride (Gdn·HCl) and 0.1 M
170 phosphate buﬀer at pH 6.2 without the addition of any other
171 exogenous additives. Equal volumes of the solutions were
172 combined to a ﬁnal concentration of 2.5 mM diselenide dimer 9
173 and 6.5 mM selenoester 10−14. In all cases the ligation reached
174 completion within 5−45 min (as judged by UPLC-MS analysis)
175 to aﬀord the ligation product as a mixture of the symmetrical
176 diselenide and the product additionally acylated at the γ-selenol
177 moiety via a trans-selenoesteriﬁcation reaction with excess
178selenoester starting material (also observed with the parent
179reaction at Sec;12 see Supporting Information). The mixture of
180ligation products formed is ultimately inconsequential, as all
181products converge to the desired native peptide following in situ
182deselenization.
183It should be noted that a ﬁne precipitate of diphenyl
184diselenide (DPDS) is produced during the ligation reaction,
185which serves as a visual indication of reaction completion.12
186Upon completion of the ligation reaction, the DPDS precipitate
187was removed via hexane extraction and the deselenization step
188was eﬀected by treatment with tris(2-carboxyethyl)phosphine
189(TCEP, 250 mM) and dithiothreitol (DTT, 20 mM) in 6 M
190Gdn·HCl/0.1 M phosphate buﬀer at pH 5.0. In situ
191deselenization of the γ-selenoproline moiety proceeded to
192completion within 16 h to aﬀord the desired native Pro-
193containing peptides. Puriﬁcation via reverse-phase HPLC
194provided 15−19 in excellent yields (51−60%) over the two
195steps. Having established that the γ-selenoproline moiety is
196competent in additive-free DSL−deselenization chemistry, we
197next investigated whether the method could be expanded to
198include C-terminal Pro selenoesters in an attempt to forge
199previously intractable Pro−Pro junctions. Importantly, polypro-
200line sequences are highly abundant in peptides and proteins
201across all taxa; more than 33% of E. coli proteins25 and ca. 25% of
202human proteins (see Supplementary Table) possess one ormore
203polyproline motifs. A method to construct such junctions would
204therefore be highly valuable. As an initial assessment of the
205ligation eﬃciency, Ac-LYRANP-SePh 20 (2.0 equiv) was
206reacted with diselenide dimer peptide 9 (1.0 equiv with respect
207to the monomer) in 6 M Gdn·HCl/0.1 M phosphate buﬀer at
208pH 6.2. While the reaction proceeded more slowly than with
209selenoesters 10−14, we were delighted to observe clean and
210 s3complete conversion within 16 h (Scheme 3A). Extraction of the
211DPDS precipitate and in situ deselenization then provided the
212desired Pro−Pro-containing peptide 21 in 54% yield over two
213steps. To our knowledge, this represents the ﬁrst successful
214example of a peptide ligation at the sterically encumbered and
215electronically disarmed Pro−Pro junction, thus providing a
216unique advantage of the DSL reaction manifold. Encouraged by
217the successful Pro−Pro ligation under the DSL manifold, we
218next explored the scope of the chemistry at another Pro-derived
219residue, namely, γ-hydroxyproline (Hyp), a common post-
220translationally modiﬁed residue found in proteins, e.g.,
221collagens. Studies began with the synthesis of model peptide
222selenoester 22, possessing a C-terminal Hyp residue (Ac-
223LYRANP(OH)-SePh, see Supporting Information for details).
224Pleasingly, the additive-free DSL reaction between 22 and 9 also
225proceeded to completion within 16 h, and, following in situ
226deselenization and puriﬁcation by HPLC, peptide product 23
227was isolated in 55% yield (Scheme 3A). In order to show that
228DSL reactions at prolyl selenoesters were also competent with
229other selenoamino acids, we next performed ligation between
230peptide selenoester 20 and peptides bearing N-terminal
231selenocystine and β-selenoaspartate residues as the correspond-
232ing diselenide dimers (see Supporting Information). These
233reactions proceeded cleanly within 16 h, and subsequent
234deselenization provided products containing Ala and Asp at
235the ligation junction in good yield.
236Pro−Pro Ligation in the Presence of Additives.
237Together with the additive-free DSL−deselenization chemistry,
238we have previously shown that diselenide peptides (with the
239exception of those bearing N-terminal β-selenoaspartate or γ-
240selenoglutamate residues22) can be successfully ligated with
Table 1. Model Ligation−Deselenization Reactions between
Diselenide Dimer 9 and Selenoesters 10−14a
entry
Ac-LYRANX-SePh
10−14 (X = )
ligation time
(min)
yield for one-pot ligation−
deselenization
1 Ala (10) 5 56% (15)
2 Met (11) 10 52% (16)
3 Tyr (12) 10 60% (17)
4 Leu (13) 10 51% (18)
5 Val (14) 45 54% (19)
aLigation: 9 and 10−14 in ligation buﬀer (6 M Gdn·HCl, 0.1 M
Na2HPO4), rt, pH 6.2, [9] = 2.5 mM, [10−14] = 6.5 mM, 5−45 min.
In situ deselenization: Hexane extraction followed by addition of an
equivalent volume of TCEP (250 mM) and DTT (20 mM) in buﬀer
(6 M Gdn·HCl, 0.1 M Na2HPO4, pH 4.5−5.5).
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241 peptide selenoesters in the presence of additives, speciﬁcally the
242 phosphine reductant TCEP. Since TCEP is able to facilitate
243 deselenization reactions, a radical-trapping agent such as
244 ascorbic acid26 or DPDS must also be used to avoid this
245 deleterious side reaction (until the ligation has reached
246 completion). We were interested in exploring whether the
247 inclusion of additives would accelerate the ligation reaction at
248 the challenging Pro−Pro junctions. We also envisaged that the
249 reductant would be capable of regenerating phenylselenolate
250 from DPDS, which would perform selenolysis of the product
251 selenoesters that are generated during the reaction, thus
252 enabling the reduction of the molar excess of the selenoester
253 component required (2.0 equiv under additive-free conditions,
254 vide supra). We chose to use TCEP as the reductant and DPDS
255 as the radical trap, which can be easily extracted prior to in situ
256 deselenization. Ligations between peptide diselenide dimer 9
257 and selenoesters 20 and 22 were repeated in the presence of
258 TCEP (50 mM) and DPDS (20 mM) using 1 equiv of the
259 selenoester component (Scheme 3A). These ligations pro-
260 ceeded to completion with only ca. 3−5% deselenization of the
261 starting diselenide dimer 9 over a period of 16 h but,
262 interestingly, did lead to substantial deselenization of the
263 ligation product. Nonetheless, upon extraction of the excess
264 DPDS with hexane and treatment with TCEP and DTT, a single
265 deselenized product could be obtained. Puriﬁcation via reverse-
266 phase HPLC aﬀorded the desired peptide products 21 and 23
267 bearing Pro−Pro and Hyp−Pro motifs in 51% and 64% yield,
268 respectively. Importantly, these experiments demonstrate that
269 DSL reactions at γ-selenoproline can be performed using
270 reductants in the presence of a radical quenching agent (in this
271 case DPDS); however, there is no beneﬁt to the rate of the
272 ligation reaction. Finally, we envisaged that the use of additives
273 in forging Pro−Pro junctions via DSL chemistry would be
274beneﬁcial for substrates possessing unprotected Cys residues.
275Speciﬁcally, the inclusion of TCEP and DPDS would enable any
276unproductive thioesters that may form to be selenolyzed with
277phenylselenolate. Toward this end, reactions were performed
278with and without additives (TCEP, DPDS) on a model peptide
279containing an unprotected internal Cys residue (see Supporting
280Information). Gratifyingly, the reactions proceeded smoothly
281and at similar rates under both additive- and additive-free
282manifolds. Following chemoselective deselenization19 of γ-Se-
283Pro, native peptides bearing an intact internal Cys residue were
284generated in good yields (see Supporting Information).
285Eﬀects of γ-Selenoproline Stereochemistry on Liga-
286tion Eﬃciency.Having shown that the reaction was tolerant of
287a number of selenoester reactants, we were next interested in
288investigating the eﬀect of the stereochemistry at the γ-position of
289the selenoproline unit on the productivity of the ligation. As
290such, we prepared cis-γ-selenoproline building block 24 using a
291similar route to that developed for 1 (Scheme 3B). Stereo-
292chemical inversion at the γ-position was eﬀected by treatment of
293a tosylated variant of γ-hydroxyproline with diselenide 5 under
294reducing conditions (see Supporting Information for full
295synthetic details). The cis-γ-selenoproline 24 was subsequently
296coupled to resin-bound peptide 7 and subjected to acidolytic
297cleavage, side-chain deprotection, and PMB removal. The ﬁnal
298HPLC-puriﬁed diselenide dimer peptide 25 bearing cis-γ-
299selenoproline was obtained in 66% yield (based on the loading
300of the ﬁrst amino acid). Interestingly, ligation of 25 to both Ac-
301LYRANP-SePh 20 and Ac-LYRANP(OH)-SePh 22, under both
302additive-free and additive conditions, failed to aﬀord the desired
303ligation product over 16 h. Instead, formation of unrearranged
304selenoesters of 25 (i.e., branched selenoesters 26 and 27) were
305observed as the major products (Scheme 3B). This was
306conﬁrmed upon treatment of 26 and 27 with aqueous hydrazine
307to eﬀect cleavage of the side-chain selenoester to reaﬀord 25 and
308form the acyl hydrazide of 20 and 22 (see Supporting
309Information). Importantly, the results of this study suggest
310that the normally rapid Se→ N acyl shift is unable to proceed
311when the γ-seleno moiety is in the S-conﬁguration, i.e., cis-
312conﬁgured with respect to the α-amine moiety.
313Computational Studies. In order to help rationalize the
314strict stereochemical requirement for the Se→N acyl shift of the
315selenoester intermediate, and therefore productive ligation at
316Pro−Pro, we turned to computational studies. Speciﬁcally, using
317model systems for the selenoester intermediate generated with
318 f1trans- and cis-γ-selenoproline diastereoisomers (Figure 1A), we
319extensively examined the possible conformational space for both
320to determine the likelihood of the acyl shift proceeding. Toward
321this end, we assessed a large number of initial conformers using a
322Monte Carlo algorithm together with molecular mechanics.
323These structures were then optimized with density functional
324theory (DFT) using the PBE/6-31G(d) method; improved
325single-point energies were subsequently obtained using the
326higher-level M06-2X/6-311G(2df,p) method (see Supporting
327Information). Using this method we found that the low-energy
328structures for the trans-isomer (e.g., I in Figure 1B) have the
329carbonyl carbon of the selenoester moiety in close proximity to
330the Pro α-NH and at a suitable geometry to facilitate the
331intramolecular acyl shift, a pathway that is observed
332experimentally. Logically, one can envisage that inversion of
333the stereochemistry at the γ-selenoproline unit would place the
334Pro α-NH away from this more optimal location. Indeed, despite
335sampling hundreds of conformations (e.g., II) for the cis-isomer,
336none place the carbonyl carbon of the selenoester in a position
Scheme 3. (A) Ligation−Deselenization between Diselenide
Dimer 9 Bearing an N-Terminal trans-γ-Selenoproline and
Selenoesters 20 and 22 under Additive-Free and Additive
Conditions;a (B) Ligation between cis-γ-Selenoproline
Diselenide Dimer 25 and Selenoesters 20 and 22 Leading to
Unrearranged Selenoester Intermediates 26 and 27
a1 equiv of 20 or 22 used in the additive reaction with 50 mM TCEP
and 20 mM DPDS.
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337 that would lead to a favorable Se→N shift with the Pro α-NH. It
338 is interesting to note that our calculations suggest that the Se→
339 N acyl shift would be further favored for the trans-isomer from
340 an acyl-selenonium species if generated under the reaction
341 conditions (see Supporting Information for data).12 In
342 summary, our DFT results explain the experimental observation
343 that the selenoesters, 26 and 27, are formed but do not
344 rearrange.
345 Synthesis of Proline-Rich Polypeptides.Having success-
346 fully developed a robust method for the one-pot DSL−
347 deselenization at γ-selenoproline and, more importantly,
348 demonstrated the ﬁrst successful ligation at Pro−Pro, we next
349 turned our attention to the application of this technology for the
350 preparation of larger polypeptides. For this purpose we ﬁrst
351 chose to target the synthesis of the Pro-rich polypeptide SMR3B
352 (submaxillary gland androgen regulated protein 3B, 28) using
353 the additive-free manifold.27 The 57-amino-acid sequence of
354 SMR3B is Cys- and Ala-free and contains a total of 30 Pro
355 residues (53%), seven of which form a centrally located
356 polyproline stretch. We envisaged a disconnection between
357 Pro27 and Pro28 within this motif that would facilitate a simple
358 two-fragment assembly via the Pro−Pro DSL−deselenization
359 method. Fragment 29 (SMR3B 1−27) bearing a C-terminal
360 proline selenoester and 30 (SMR3B 28−57) containing an N-
361 terminal trans-γ-selenoproline diselenide dimer were ﬁrst
362synthesized via Fmoc-SPPS on 2-chlorotrityl chloride resin
363(see Supporting Information). The resulting fragments 29 (10
364mM ﬁnal conc) and 30 (5 mM ﬁnal conc with respect to the
365monomer) were then subjected to ligation in 6 M Gdn·HCl/0.1
366M phosphate buﬀer at a ﬁnal pH of 6.4. The reaction was
367monitored by UPLC-MS and reached completion within 16 h.
368Extraction of the precipitated DPDS with hexane, followed by in
369situ deselenization with TCEP and DTT, successfully generated
370the native polypeptide. Puriﬁcation via reverse-phase HPLC
371then provided SMR3B 28 in 52% yield.
372In addition to SMR3B, we also chose to prepare the 62-
373amino-acid antimicrobial peptide lumbricin-1 via one-pot DSL−
374deselenization chemistry at γ-selenoproline. Lumbricin-1 is a
375Pro-rich peptide (15% Pro content) isolated from the
376earthworm Lumbricius rubellus.28 It has been shown to exhibit
377antimicrobial activity in vitro against a broad spectrum of
378microorganisms including Gram-positive (e.g., Staphylococcus
379aureus) and Gram-negative bacteria (e.g., E. coli) as well as some
380fungi (e.g., Candida albicans). Given the absence of Cys or
381suitably positioned Ala residues in the sequence, together with
382the abundance of Pro, lumbricin-1 was considered a second ideal
383 s4target to showcase the DSL−deselenizationmethod at Pro−Pro.
384We chose to disconnect lumbricin-1 (31) centrally between
385Pro33 and Pro34 for assembly through additive-free DSL−
386deselenization in one pot. This led to two peptide targets for
387synthesis, the 33-amino-acid peptide 32, bearing a C-terminal
388Pro selenoester, and peptide dimer 33, bearing an N-terminal
389trans-γ-selenoproline. Both fragments were synthesized on 2-
390chlorotrityl chloride resin via Fmoc-SPPS (see Supporting
391Information for details). Fragments 32 (10 mM ﬁnal conc) and
39233 (5 mM ﬁnal conc with respect to the monomer) were then
393ligated by dissolving in 6MGdn·HCl/0.1M phosphate buﬀer at
394a ﬁnal pH of 6.2. The reaction was monitored by UPLC-MS and
395reached completion within 16 h. On this occasion extraction of
396the DPDS, followed by in situ deselenization with TCEP and
397DTT, did not proceed to completion, attributed to the inability
398of DTT to thiolyze the product selenoester generated in the
399reaction. Therefore, the ligation was repeated and, upon
400completion, the crude reaction mixture was treated with 2 vol
401% hydrazine for 10 min, which led to complete hydrazinolysis of
402the product selenoester, generating diselenide ligation product
40334 exclusively. Hexane extraction of residual DPDS, in situ
404deselenization with TCEP and DTT, and puriﬁcation via
405reverse-phase HPLC then aﬀorded lumbricin-1 (31) in 52%
406yield over two steps. The synthetic lumbricin-1 was
407subsequently assessed for activity against Staphylococcus aureus
408(SH1000 strain) and exhibited activity consistent with that
409reported for thematerial isolated from the earthworm (IC50 = 80
410 s5μM).28
411■ CONCLUSIONS
412In summary, an eﬃcient one-pot DSL−deselenization strategy
413has been developed at γ-selenoproline that has enabled access to
414Pro−Pro ligation sites for the ﬁrst time. The reaction was shown
415to be equally eﬃcient with or without the inclusion of reductive
416additives. However, the stereochemistry of the γ-selenol moiety
417was shown to be crucial for peptide bond formation. The power
418of this technology was demonstrated via a one-pot synthesis of
419submaxillary gland androgen regulated protein 3B and the
420antimicrobial peptide lumbricin-1 in excellent overall yields. The
421simplicity and eﬃciency of the ligation−deselenization chem-
422istry developed here should see this technology applied to the
423synthesis of numerous Pro-rich peptide and protein targets in
Figure 1. Proposed selenoester intermediates for trans- (I, not observed
experimentally) and cis- (II, observed experimentally) γ-selenoproline
isomers: (A) ChemDraw representations; (B) low-energy structures.
Hydrogen atoms are omitted for clarity.
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424 the future, particularly those that can only be accessed via Pro-
425 Pro/Hyp-Pro ligations, e.g., antimicrobial peptides and
426 collagens.
427 ■ EXPERIMENTAL SECTION
428 One-Pot Additive-Free DSL−Deselenization at Proline−
429 Proline. Peptide prolyl selenoesters (2.0 equiv) and N-terminal
430 selenoproline diselenide dimer peptides (1.0 equiv with respect to the
431 monomer) were dissolved separately in ligation buﬀer (6 M Gdn·HCl/
432100 mM Na2HPO4, pH 7.2). The solutions were combined to give an
433overall concentration of 10 mM with respect to the peptide selenoester
434and 5 mM with respect to monomeric selenoproline peptide, and the
435pH was adjusted to 6.2−6.5 with aqueous 1 M NaOH. The ligation
436progress was monitored by UPLC-MS until the selenoproline peptide
437was completely consumed. The precipitated DPDS was extracted from
438the crude ligation solution with hexane (×3). The solution was then
439thoroughly degassed with Ar(g) sparging. To eﬀect deselenization, an
440equal volume of degassed buﬀer containing TCEP (0.25 M) and DTT
Scheme 4. (A) Primary Structure of SMR3B; (B) Synthesis of SMR3B (28) via a One-Pot Additive-Free Ligation−Deselenization
of Fragments 29 and 30; (C) Analytical HPLC and ESI Mass Spectrum (Inset) of Puriﬁed Synthetic SMR3B; (D) MALDI-TOF
Mass Spectrum of Puriﬁed Synthetic SMR3B
Scheme 5. (A) Primary Structure of Lumbricin-1; (B) Synthesis of Lumbricin-1 (31) via a One-Pot Additive-Free Ligation−
Deselenization of Fragments 32 and 33; (C) Analytical HPLC and ESIMass Spectrum (Inset) of Puriﬁed Synthetic Lumbricin-1;
(D) MALDI-TOF Mass Spectrum of Puriﬁed Synthetic Lumbricin-1
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441 (20 mM) at pH 4.5−5.5 was added. Following the completion of the
442 reaction (16 h), the solution was puriﬁed via semipreparative reverse-
443 phase HPLC (see Supporting Information for column and gradient
444 information). All peptides were isolated as white solids following
445 lyophilization.
446 One-Pot Additive DSL−Deselenization at Proline−Proline.
447 The N-terminal selenoproline diselenide dimer (1.0 equiv with respect
448 to the monomer) was dissolved in a solution of TCEP (100 mM) and
449 DPDS (40 mM) in ligation buﬀer (6 M Gdn·HCl/100 mM Na2HPO4,
450 pH 6−7). The proline selenoester peptide (1.0 equiv) was dissolved
451 separately in ligation buﬀer to a concentration of 10 mM. The two
452 solutions were combined to give an overall concentration of 5 mMwith
453 respect to both peptide fragments (ﬁnal additive concentrations: 50
454 mM TCEP, 20 mM DPDS), and the pH was adjusted to 6.2−6.5. The
455 ligation reaction was allowed to proceed to completion (as judged by
456 analytical UPLC and UPLC-MS analysis). The precipitated DPDS was
457 extracted from the crude ligation solution with hexane (×3). The
458 solution was then thoroughly degassed with Ar(g) sparging. To eﬀect
459 deselenization, an equal volume of degassed buﬀer containing TCEP
460 (0.25 M) and DTT (20 mM) at pH 4.5−5.5 was added. Following the
461 completion of the reaction (16 h), the solution was puriﬁed via
462 semipreparative reverse-phase HPLC (see Supporting Information for
463 column and gradient information), and the desired ligation products
464 were isolated as white solids following lyophilization.
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